Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06017687 · ClinicalTrials.gov registry record · NA
Data Collection and Evaluation of OptiBP Under Investigational Use
A NA study of General Population, sponsored by Biospectal.
- Recruiting
- Registry status
- NA
- Development phase
- 500,000
- Enrollment target
- 1
- Study location
NCT06017687 is a NA study of General Population that is actively recruiting participants, run by Biospectal. The registered enrollment target is 500,000 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06017687, a NA study of General Population, is actively recruiting participants, sponsored by Biospectal.
- RECRUITING
- Registry status
- NA
- Development phase
- 500,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.
Conditions Studied
Interventions
- DEVICE OptiBP Study app
Study Locations (1)
California
- Decentralized Trial - Truckee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500,000 participants |
| Start Date | 2023-09-28 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06017687
The ClinicalTrials.gov registry entry for NCT06017687 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biospectal, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with General Population appearing as the primary indexed condition, and to 1 intervention - of which OptiBP Study app is the first listed.
NCT06017687 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06017687 about?
NCT06017687 is a clinical study titled "Data Collection and Evaluation of OptiBP Under Investigational Use". The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.
What is the current status of trial NCT06017687?
This trial is currently recruiting. It is a NA study. The enrollment target is 500,000 participants. The study started on 2023-09-28. Estimated completion is 2026-09.
What conditions does trial NCT06017687 study?
This clinical trial studies the following conditions: General Population.
What interventions are being tested in trial NCT06017687?
The interventions under investigation include: OptiBP Study app (DEVICE).
Who is sponsoring clinical trial NCT06017687?
This trial is sponsored by Biospectal, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06017687 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for General Population
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.